Other biomarkers, such as cerebrospinal fluid beta-amyloid 1–42, total tau, phosphorylated tau and unphosphorylated total alpha-synuclein showed no significant differences according to gender as demonstrated in a study conducted on 361 PD patients. The gene discussed is SNCA; the disease is Parkinson disease.